Tuesday, September 22, 2026

$FOUR: Shift4 at 6.5x EBITDA. Is the organic growth real? | Emeth Value Capital

Shift4 trades at 6.5x EBITDA despite 11% reported organic growth, with Shift4 Dine equipment leases cited as evidence of net-new merchant additions.

FOUR $3B

Yet Another Value Podcast Sep 22 22 clicks

Sep 22 CRWV $49B

CoreWeave, Inc (CRWV)

SixSigmaCapital: Navigating the Financial Markets 10 clicks

Sep 22 TXN $260B

Analog Semiconductor Smorgasbord, Feat. TXN, ON, VSH

Cestrian Capital Research 7 clicks

From X

@MaiusPartners Sep 22 5 clicks

Maius on X

Love it or hate it, but the $GNRC / $AMZN deal is an extremely bearish read-through for the legacy backup power suppliers $CMI / $CAT. The equivalent would be $GM coming to China and taking 20% of the market overnight from BYD. https://t.co/loOU0ZaB7V

@BarbarianCap Sep 22 4 clicks

Barbarian Capital on X

AutoZone Expects Growth to Accelerate This Fiscal Year $AZO https://t.co/FYkgVNrID5

@BarbarianCap Sep 22 8 clicks

Barbarian Capital on X

mentioned: $SCHW $LPLA $RJF $AMP $JPM $BAC $BKNG Meta’s Muse Comes for Financial Stocks https://t.co/dqxVL8KJ2U

@BarbarianCap Sep 22 1 click

Barbarian Capital on X

KB Home Cuts Margin Outlook as Housing Conditions Worsen $KBH https://t.co/OA4utledZC

@BarbarianCap Sep 22 3 clicks

Barbarian Capital on X

$FUN Activist Jana Partners Urges Six Flags to Explore Sale https://t.co/ifMKt79541

@leevalueroach Sep 22 3 clicks

Lee Roach on X

This is why I think Ryan Cohen put up $46 million dollars into $GME over the past few weeks along with other large insider buys. Pokemon card sales reached an all time high in August. Then in September it was Pokemon's 30th anniversary. It was the biggest coordinated event for Pokemon cards in history. Stores were sold out. Lines all over. GameStop probably made a killing. And this anniversary will continue until the end of the year with more sets dropping in Q4, which is the best quarter. GameStop is going to smoke the $650 million of EBITDA for 2026. I have it closer to $885 million. The core business is on fire. Get more info here: https://t.co/Re7vRQ6uHG

@partners_road Sep 22 3 clicks

RiverRoadPartners on X

Some huge options trades (tech, naturally) today. Over a billion of premium paid and a lot of vega as well ($20M+). $AMD, $AAPL, $AVGO and $DELL. All January ‘28.

@finphysnerd Sep 22 4 clicks

Myles on X

@HatfieldCapital @RealHerbHoover From what I've read $MMS has some exposure to va healthcare repricing as well. More importantly the rest of the business is lower quality. No defence/intelligence exposure, some segments overearning (natural disaster work and soft services volumes). Still looks cheap.

Monte Investments Market Brief Vol. CXXVIII

Firefly Aerospace grew backlog to $1.5 billion, won two 2028 lunar missions and acquired Space-ng for autonomous navigation across its Blue…

FLY $3.8B

Monte Independent Investment Research Sep 22 10 clicks

Cellebrite (CLBT) Management Meeting: The Road Ahead

Cellebrite converts more than 110% of EBITDA into free cash flow and trades at 12.5 times free cash flow, with management targeting 15% or…

CLBT $2.9B

Aurelion Research Sep 22 10 clicks

Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy

Abbott’s Exact Sciences acquisition raises leverage, leaving Medical Devices’ 8% growth and 33.9% margin to carry cash flow until…

ABT $173B

PV Research Sep 22 2 clicks

Meta's Muse Could be Big Win for Innodata

Innodata's new Meta contract for long-horizon agent personalization ties the data company to Meta's Muse AI assistant, despite Meta's Scale…

INOD $2.2BMETA $1.9T

Hunterbrook Sep 22 13 clicks

Emeth Value Capital’s Andrew Carreon on Shift4 ($FOUR)

Shift4 trades at 6.5 times EBITDA despite 11% organic growth, with Shift4 Dine equipment leases reaching a $400 million run rate as…

FOUR $3B

Yet Another Value Blog Sep 22 5 clicks

Credo Technology: New Position in My Private Portfolio

Credo Technology was added at $170.54 after a 40% selloff, backed by its high-speed AECs and optical connectivity for AI data centers.

CRDO $40B

Hated Moats Sep 22 19 clicks

Copart's Return To Growth Starts Now: Adair's $1.9B Bet On ACV Auctions

Copart’s $1.9 billion ACV Auctions acquisition targets renewed growth, with EPS accretion expected by fiscal 2028 as insurance…

ACVA $1.8BCPRT $25B

Robert J. Lake Sep 22 3 clicks

GameStop Is Extreme Deep Value

GameStop's collectibles mix rose to 45% of sales as gross margin reached 44%, supporting a deep-value case built on cash and store…

GME $13B

The Value Road Sep 21 9 clicks

Tempus AI: Data And Applications Will Unlock More Upside

Tempus AI’s Q2 oncology testing volumes rose 31%, while data and applications revenue grew 28% as its clinical data flywheel expands.

TEM $15B

Bay Area Ideas Sep 21 3 clicks

Meta’s Muse Is No Sure Thing

Meta’s Muse AI agent drove an 11% share surge, but OpenAI, Google and Apple could erode its early consumer lead.

META $1.9T

Key Context by Tae Kim Sep 21 5 clicks

CBT · short

Cabot CORP

Cabot’s short case targets a market pricing FY26 EPS of $6.00–$6.50 as trough earnings and assigning value to its battery-materials…

CBT $3.9B

Value Investors Club May 2 2 clicks

Dave & Buster’s Entertainment ($PLAY) Management Sees Potentially $1B+ in Incremental EBITDA in 2025, Will Investors? One Hour Analysis

Dave & Buster’s targets $1 billion-plus of incremental EBITDA by 2025 through marketing, food-and-beverage attachment and game pricing,…

PLAY $229M

Investing 501 Sep 15 3 clicks

Purecycle and the good money after bad decision...

PureCycle’s largest shareholder, Sylebra Capital, keeps financing its delayed, over-budget plastic-recycling plant despite covenant…

PCT $822M

John Hempton's Newsletter Aug 21 3 clicks

We can get some extra votes. Pity they are worthless and scumbags are in charge of governance.

Campari’s five-year loyalty plan grants five votes per share, letting its controlling shareholder sell stock while retaining control and…

DVCMY $8.2B

John Hempton's Newsletter Aug 7 2 clicks

Value Roundup

Talen’s post-bankruptcy nuclear assets, FREIT’s $22 Kushner bid and Calithera’s failed liquidation vote illustrate unusual small-cap…

TLN $18BFREVS $118M

Exploring with Alluvial Capital Jul 5 1 click

Going Nuclear with Nuveen

Nuveen municipal-bond closed-end funds could unlock illiquid Energy Harbor holdings through Vistra’s acquisition, receiving cash and a…

VST $49BFE $26B

Exploring with Alluvial Capital Mar 21 1 click

Letters, Presentations, and More!

Alluvial Capital’s Q3 update values We.Connect at a mid-single-digit earnings multiple, flags LICT’s $128 million rural-broadband grant,…

LICT $199MMRTI $89M

Exploring with Alluvial Capital Nov 22 1 click

Essex Biotechnology (1061 HK) - Core products fund investment portfolio

Essex Biotechnology trades at 8 times earnings despite patented Chinese biologics, near-60% niche market share and a portfolio built with…

PFE $160B

Healthy Stock Picks Apr 5 1 click

Tuesday, September 22, 2026

$FOUR: Shift4 at 6.5x EBITDA. Is the organic growth real? | Emeth Value Capital

CoreWeave, Inc (CRWV)

Analog Semiconductor Smorgasbord, Feat. TXN, ON, VSH

From X

Maius on X

Barbarian Capital on X

Barbarian Capital on X

Barbarian Capital on X

Barbarian Capital on X

Lee Roach on X

RiverRoadPartners on X

Myles on X

Investor Letters

Monte Investments Market Brief Vol. CXXVIII

Cellebrite (CLBT) Management Meeting: The Road Ahead

Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy

Meta's Muse Could be Big Win for Innodata

Emeth Value Capital’s Andrew Carreon on Shift4 ($FOUR)

Credo Technology: New Position in My Private Portfolio

Copart's Return To Growth Starts Now: Adair's $1.9B Bet On ACV Auctions

GameStop Is Extreme Deep Value

Tempus AI: Data And Applications Will Unlock More Upside

Meta’s Muse Is No Sure Thing

Cabot CORP

Dave & Buster’s Entertainment ($PLAY) Management Sees Potentially $1B+ in Incremental EBITDA in 2025, Will Investors? One Hour Analysis

Purecycle and the good money after bad decision...

We can get some extra votes. Pity they are worthless and scumbags are in charge of governance.

Value Roundup

Going Nuclear with Nuveen

Letters, Presentations, and More!

Essex Biotechnology (1061 HK) - Core products fund investment portfolio

Publications we follow

YouTube 4

Blogs 12

Seeking Alpha 43 of 211

X accounts we follow

Investor letters we follow

Sectors

Tuesday, September 22, 2026

Maius on X

Barbarian Capital on X

Barbarian Capital on X

Barbarian Capital on X

Barbarian Capital on X

Lee Roach on X

RiverRoadPartners on X

Myles on X

Investor Letters

Publications we follow

Newsletters 92

YouTube 4

Blogs 12

Seeking Alpha 43 of 211

X accounts we follow

Investor letters we follow

Sectors